Canaccord Genuity Maintains Buy on Blend Labs, Lowers Price Target to $3

Benzinga · 1d ago
Canaccord Genuity analyst Joseph Vafi maintains Blend Labs (NYSE:BLND) with a Buy and lowers the price target from $4.5 to $3.